Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-11

Clinical Trial Update: Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease [NA]

View source ↗

Summary

This clinical trial is evaluating fecal microbiota transplantation as a first-line treatment for active pediatric Crohn's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Tongji Hospital | Conditions: Crohn Disease | NA | Status: RECRUITING